Hannah R. Nicholas

Hannah R. Nicholas

Auto-generated profile, based on publicly available information

Hannah R. Nicholas

School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Genetics
Verified
Journal Article
Closed access
PDF file
MGMaria J. Gravato-Nobre
Maria J. Gravato-Nobre
HNHannah R. Nicholas
Hannah R. Nicholas
RNReindert Nijland
Reindert Nijland
DODelia O'Rourke
Delia O'Rourke
DWDeborah E Whittington
Deborah E Whittington
JHJonathan Hodgkin
Jonathan Hodgkin
Interactions with bacteria play a major role in immune responses, ecology, and evolution of all animals, but they have been neglected until recently in the case of C. elegans. We report a genetic investigation of the interaction of C. elegans with the nematode-specific pathogen Microbacterium nematophilum, which colonizes the rectum and causes distinctive tail swelling in its host. A total of 121 mutants with altered response to infection were isolated from selections or screens for a bacterially unswollen (Bus) phenotype, using both chemical and transposon mutagenesis. Some of these correspond to known genes, affecting either bacterial adhesion or colonization (srf-2, srf-3, srf-5) or host swelling response (sur-2, egl-5). Most mutants define 15 new genes (bus-1–bus-6, bus-8, bus-10, bus-12–bus-18). The majority of these mutants exhibit little or no rectal infection when challenged with the pathogen and are probably altered in surface properties such that the bacteria can no longer infect worms. A number have corresponding alterations in lectin staining and cuticle fragility. Most of the uninfectable mutants grow better than wild type in the presence of the pathogen, but the sur-2 mutant is hypersensitive, indicating that the tail-swelling response is associated with a specific defense mechanism against this pathogen.

1 July 2004 in Current Biology
Verified
Journal Article
Closed access
HNHannah R Nicholas
Hannah R Nicholas
JHJonathan Hodgkin
Jonathan Hodgkin

1 July 2004 in Molecular Immunology
Verified
Journal Article
Closed access
HNHannah R. Nicholas
Hannah R. Nicholas
JHJonathan Hodgkin
Jonathan Hodgkin

1 October 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SESally A. Eaton
Sally A. Eaton
AFAlister P. W. Funnell
Alister P. W. Funnell
NSNancy Sue
Nancy Sue
HNHannah Nicholas
Hannah Nicholas
RPRichard C. M. Pearson
Richard C. M. Pearson
MCMerlin Crossley
Merlin Crossley
Transcription factors of the Sp/Klf (Krüppel-like factor) family regulate biological processes such as hematopoiesis, adipogenesis, and stem cell maintenance. Here we show that Bklf or Klf3 (Basic Krüppel-like factor) represses the Klf8 (Krüppel-like Factor 8) gene in vivo. Conversely, Eklf or Klf1 (Erythroid Krüppel-like factor) activates the Klf8 gene. Klf8 is driven by two promoters, both of which contain multiple CACCC sites. Klf3 can repress Klf1-mediated activation of both promoters. Chromatin immunoprecipitation experiments confirm that Klf3 occupies both Klf8 promoters in vivo. Interestingly, in Klf3 knock-out tissue Klf1 gains access, binds, and activates both Klf8 promoters. These results demonstrate direct competition between activating and repressing Klfs in vivo. Together with previous evidence that Klf1 directly activates the Klf3 gene, the results reveal an elaborate network of cross-talk within the Klf family. The recognition of cross-regulation and potential redundancy between Klf family members is critical to the interpretation of various Klf knock-out mice and the understanding of individual Klfs in particular contexts.

24 January 2014 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
VLVanessa Liang
Vanessa Liang
MUMilena Ullrich
Milena Ullrich
HLHong Lam
Hong Lam
YCYee Lian Chew
Yee Lian Chew
Samuel BanisterSamuel Banister
Samuel Banister
HNHannah R. Nicholas
Hannah R. Nicholas
Protein misfolding and aggregation as a consequence of impaired protein homeostasis (proteostasis) not only characterizes numerous age-related diseases but also the aging process itself. Functionally related to the aging process are, among others, ribosomal proteins, suggesting an intimate link between proteostasis and aging. We determined by iTRAQ quantitative proteomic analysis inC. eleganshow the proteome changes with age and in response to heat shock. Levels of ribosomal proteins and mitochondrial chaperones were decreased in aged animals, supporting the notion that proteostasis is altered during aging. Mitochondrial enzymes of the tricarboxylic acid cycle and the electron transport chain were also reduced, consistent with an age-associated energy impairment. Moreover, we observed an age-associated decline in the heat shock response. In order to determine how protein synthesis is altered in aging and in response to heat shock, we complemented our global analysis by determining the de novo proteome. For that, we established a novel method that enables both the visualization and identification of de novo synthesized proteins, by incorporating the non-canonical methionine analogue, azidohomoalanine (AHA), into the nascent polypeptides, followed by reacting the azide group of AHA by ‘click chemistry’ with an alkyne-labeled tag. Our analysis of AHA-tagged peptides demonstrated that the decreased abundance of, for example, ribosomal proteins in aged animals is not solely due to degradation but also reflects a relative decrease in their synthesis. Interestingly, although the net rate of protein synthesis is reduced in aged animals, our analyses indicate that the synthesis of certain proteins such as the vitellogenins increases with age.

1 January 2013 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
JGJürgen Götz
Jürgen Götz
DXDi Xia
Di Xia
GLGerhard Leinenga
Gerhard Leinenga
YCYee Lian Chew
Yee Lian Chew
HNHannah Nicholas
Hannah Nicholas
TAU is a microtubule-associated protein that under pathological conditions such as Alzheimer’s disease forms insoluble, filamentous aggregates. When twenty years after TAU’s discovery the first TAU transgenic mouse models were established, one declared goal that was achieved was the modelling of authentic TAU aggregate formation in the form of neurofibrillary tangles. However, as we review here, it has become increasingly clear that TAU causes damage much before these filamentous aggregates develop. In fact, because TAU is a scaffolding protein, increased levels and an altered subcellular localisation (due to an increased insolubility and impaired clearance) result in the interaction of TAU with cellular proteins with which it would otherwise either not interact or do so to a lesser degree, thereby impairing their physiological functions. We specifically discuss the non-axonal localization of TAU, the role phosphorylation has in TAU toxicity and how TAU impairs mitochondrial functions. A major emphasis is on what we have learned from the four available TAU knock-out models in mice, and the knock-out of the TAU/MAP2 homologue PTL-1 in worms. It has been proposed that in human pathological conditions such as Alzheimer’s disease, a rare toxic TAU species exists which needs to be specifically removed to abrogate TAU’s toxicity and restore neuronal functions. However, what is toxic in one context may not be in another, and simply reducing, but not fully abolishing TAU levels may be sufficient to abrogate TAU toxicity.